Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan;14(1):111-26.
doi: 10.1517/14740338.2015.972363. Epub 2014 Oct 17.

Drug-induced uveitis

Affiliations
Review

Drug-induced uveitis

Miguel Cordero-Coma et al. Expert Opin Drug Saf. 2015 Jan.

Abstract

Introduction: Drug-induced uveitis is a well described but often overlooked and/or misdiagnosed adverse reaction to medication. There are an increasing number of medications that have been related to the onset of intraocular inflammation. Identification of these inciting agents may decisively help the diagnostic algorithm involving new cases of uveitis.

Areas covered: This review intends to be an updated comprehensive, practical guide for practitioners regarding the main drugs that have been associated with uveitis. A classification proposed by Naranjo et al. in 1981 for establishing potential causality is applied examining possible mechanisms of action. A guide for clinicians about the rationale of these observations when dealing with patients with uveitis is provided.

Expert opinion: Several agents with different routes of administration (systemic, topical and/or intraocular) may cause intraocular inflammation. The mechanism behind ocular inflammation is frequently unknown. Clinicians should be aware of the potential drug effect to optimize diagnosis and management of such patients.

Keywords: VEGF; bisphosphonates; cidofovir; diethylcarbamazine; drug-induced uveitis; drug-related side effects; metipranolol; prostaglandins; quinolones; rifabutin; sulfonamides; uveitis; vaccines.

PubMed Disclaimer

LinkOut - more resources